Company: LGNZZ
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0000886163-25-000040
Chunk: 1

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-06-09
Form: 8-K
Item: Item 5.07
Chunk 1
---
 Company’s named executive officers. In accordance with the results below, the proposal was approved.

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  15,576,200          1,183,843           59,973             1,363,582  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          LIGAND PHARMACEUTICALS INCORPORATED       
  Date: June 9, 2025      By: /s/ Andrew Reardon